Quantifying the k-shaped recovery

Damien Klassen

Nucleus Wealth

I have a working theory that the September quarter earnings (Q3) coming out over the next few weeks are going to give excellent insight to the new normal.

Q1 earnings were mostly pre-COVID. Q2 was in the middle of the lockdowns and so not representative. Q3 giving us our first clean(ish) look at what we can expect if current conditions continue.

It isn’t how far profits fall, it is how far they get back up

COVID has created some huge falls in profitability as economies shut down. That doesn’t matter if the falls are temporary. Given the size of the percentage falls and rebounds, we find it more enlightening to ignore 2020 and look at the changes between 2019 and 2021.

A “k” shaped recovery

The winning letter for the shape of the economic recovery seems to be “k”.

Half of the companies doing well and half doing badly. The stats support the theme:

At a regional level some interesting stats show up:

Inverse virus performance for profit rebound?

At an aggregate level, the performance by region actually seems to be the opposite of the virus performance. i.e. the more infected and the more dead, the sooner profits recover.

Industry performance is where the action is

Breaking the companies down by industry shows the error in the simplistic interpretation of the country data. The real difference between winners and losers is at the sector level.

The US has a much greater exposure to health and technology companies which are doing way better. The manufacturing and industrial companies which dominate some of the other regions populate the lower half of the k.

Finding value is still the problem

Companies where profits are looking the strongest also tend to be expensive. There are two main areas we are looking:

  • Higher quality companies in the middle of the distribution with little downside. Some of these were left behind (from a value perspective) as markets swept higher and offer decent relative value.
  • Stocks priced for an earnings disaster when the earnings are more likely to be “only” very bad. It is a more risky area of the market, but with many stocks priced for perfection, it is one of the few places left to find value.

Not already a Livewire member?

Sign up today to get free access to investment ideas and strategies from Australia’s leading investors.

The information on this blog contains general information and does not take into account your personal objectives, financial situation or needs. Past performance is not an indication of future performance. Damien Klassen is an authorised representative of Nucleus Wealth Management, a Corporate Authorised Representative of Nucleus Advice Pty Ltd - AFSL 515796.

1 topic

Damien Klassen
Head of Investment
Nucleus Wealth

Damien runs asset allocation and global stock portfolios for Nucleus Super, Nucleus Ethical and Nucleus Wealth. His 25 year+ career includes Global Quant at Schroders, Strategy at Wilson HTM & co-founder of Aegis.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.